600222 Henan Taloph Pharmaceutical Stock
- 5.13
- -0.04-0.77%
Henan Taloph Pharmaceutical Stock News
Tarong Pharmaceutical Investor Relations Activity Record List (April 2024)
Announcement of Resolutions of the 23rd Meeting of the 9th Board of Directors of Tailong Pharmaceutical
Announcement of Resolutions of the 16th Meeting of the 9th Board of Supervisors of Tailong Pharmaceutical
Announcement of Tarong Pharmaceutical's progress in providing guarantees to wholly-owned subsidiaries
Announcement of Tailong Pharmaceutical on holding the 2023 Annual Results Briefing
Asset evaluation report for the goodwill impairment test project formed by Henan Tailong Pharmaceutical Co., Ltd.'s acquisition of Beijing New Leading Pharmaceutical Technology Development Co., Ltd.
Tailong Pharmaceutical 2023 Financial Statement Audit Report
Independent director work system
Management Measures for Selecting and Hiring Accounting Firms
Special audit report on the summary table of non-operating capital occupation and other related capital transactions of Tailong Pharmaceutical
Tailong Pharmaceutical 2023 Internal Control Audit Report
Evaluation report of Henan Tailong Pharmaceutical Co., Ltd. on the performance of accounting firms in 2023
2023 Annual Debriefing Report of the Independent Director of Tailong Pharmaceutical (Liu Yumin)
Special opinion of the board of directors of Tailong Pharmaceutical on the independence of independent directors
2023 Annual Debriefing Report of the Independent Director of Tailong Pharmaceutical (Yin Xiaohua)
Remuneration management measures for directors, supervisors and senior management
2023 Annual Debriefing Report of the Independent Director of Tailong Pharmaceutical (Fang Liang)
Announcement of Tailong Pharmaceutical on the company's application for comprehensive credit lines from banks and other financial institutions in 2024
Announcement of Tailong Pharmaceutical on the 2024 forecast to provide guarantees for its wholly-owned and holding subsidiaries
Announcement of Resolutions of the 15th Meeting of the 9th Board of Supervisors of Tailong Pharmaceutical
Analysis
Price Target
No Data
